Psychedelics valuations are in the doldrums, smack dab in the middle of the worst biotech downturn of the past 20 years.
Share this post
Psychedelics firms: Beware the coming…
Share this post
Psychedelics valuations are in the doldrums, smack dab in the middle of the worst biotech downturn of the past 20 years.